Dexcom is pleased to announce that coverage for Dexcom G6 rtCGM System on the Non-Insured Health Benefits Program has been expanded to include all clients living with type 1 diabetes. This announcement expands upon coverage already in place for clients aged 2 to 19 on intensive insulin therapy, giving even more First Nations and Inuit people access to this standard of care, potentially helping them to have more control over a life-long chronic illness.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DXCM: